Skip to main content
Clinical Trials/NCT03630276
NCT03630276
Unknown
Not Applicable

Evaluation of Neutrophil/Lymphocyte Ratio, Platelet /Lymphocyte Ratio and CRP as Markers of Severity of Pre-eclampsia

Ain Shams University1 site in 1 country111 target enrollmentAugust 1, 2018
ConditionsPre-Eclampsia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pre-Eclampsia
Sponsor
Ain Shams University
Enrollment
111
Locations
1
Primary Endpoint
PREECLAMPSIA
Last Updated
7 years ago

Overview

Brief Summary

Evaluation of neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP as markers of severity of Pre-eclampsia

Registry
clinicaltrials.gov
Start Date
August 1, 2018
End Date
August 10, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Shaza Mohamed Elreweny

Shaza Mohamed Elreweny

Ain Shams University

Eligibility Criteria

Inclusion Criteria

  • PREECLAMPSIA from 25_45years

Exclusion Criteria

  • chronic diseases Primary hypertension

Outcomes

Primary Outcomes

PREECLAMPSIA

Time Frame: 6months

Study Sites (1)

Loading locations...

Similar Trials